You are here

Mattek Corporation

Company Information
Address
200 Homer Ave
Ashland, MA 01721-1717
United States



Information

UEI: Q1V1JV6GJW77

# of Employees: N/A


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. Reconstructed Human Oral Tissues

    Amount: $0.00

    DESCRIPTION (provided by applicant): Phase I research adapted primary culture methods to obtain a reliable source of normal human buccal epithelial (NHBE) cells. Tissue culture methods were developed ...

    SBIRPhase I2003Department of Health and Human Services National Institutes of Health
  2. HIGHLY DIFFERENTIATED TISSUE CULTURE MODELS OF MELANOMA

    Amount: $152,197.00

    DESCRIPTION (provided by applicant): With the exception of lung cancer in women, the incidence of cutaneous melanoma (CM) is increasing faster than any other cancer. Current estimates are that one of ...

    SBIRPhase I2002Department of Health and Human Services National Institutes of Health
  3. RECONSTRUCTION OF SKIN MODEL CONTAINING LANGERHANS CELLS

    Amount: $0.00

    DESCRIPTION (provided by applicant): Phase I research demonstrated that a Langerhans cell (LC) containing model of the epidermis is feasible. LC progenitor cells were harvested from peripheral or co ...

    SBIRPhase I2002Department of Health and Human Services National Institutes of Health
  4. RECONSTRUCTION OF SKIN MODEL CONTAINING LANGERHANS CELLS

    Amount: $830,929.00

    DESCRIPTION (provided by applicant): Phase I research demonstrated that a Langerhans cell (LC) containing model of the epidermis is feasible. LC progenitor cells were harvested from peripheral or co ...

    SBIRPhase II2002Department of Health and Human Services National Institutes of Health
  5. IN VITRO SKIN MODEL FOR PERCUTANEOUS ABSORPTION STUDIES

    Amount: $181,352.00

    DESCRIPTION (provided by the applicant): The ability to produce skin in vitro with barrier properties equivalent to those of native epidermis remains a much sought after goal. The current ...

    SBIRPhase I2002Department of Health and Human Services National Institutes of Health
  6. HUMAN TISSUE MODEL FOR HETEROSEXUAL HIV TRANSMISSION

    Amount: $0.00

    Phase I research adapted primary culture methods to obtain a reliable source of normal ectocervico-vaginal (ECV) epithelial and Langerhans precursor (LP) cells. Tissue culture conditions were develope ...

    SBIRPhase I2002Department of Health and Human Services National Institutes of Health
  7. HUMAN TISSUE MODEL FOR HETEROSEXUAL HIV TRANSMISSION

    Amount: $1,073,017.00

    Phase I research adapted primary culture methods to obtain a reliable source of normal ectocervico-vaginal (ECV) epithelial and Langerhans precursor (LP) cells. Tissue culture conditions were develope ...

    SBIRPhase II2002Department of Health and Human Services National Institutes of Health
  8. N/A

    Amount: $100,000.00

    N/A

    SBIRPhase I2001Department of Health and Human Services National Institutes of Health
  9. Development of a Vaccine for the Treatment and/or Prevention of Cancer

    Amount: $780,000.00

    Prostate cancer is the most common non-skin malignancy in the United States. With the exception of lung cancer, it is the leading cause of death in men in the country. By age 80, the risk of develop ...

    SBIRPhase II2001Department of Defense Army
  10. Development of a Vaccine for the Treatment and/or Prevention of Cancer

    Amount: $70,000.00

    Prostate cancer is the most common non-skin malignancy in the United States. With the exception of lung cancer, it is the leading cause of death in men in the country. By age 80, the risk of develop ...

    SBIRPhase I2001Department of Defense Army
US Flag An Official Website of the United States Government